Biocon, Cipla, Dr Reddy’s, Other Pharma Stocks In Red Amid Trump Tariff Uncertainty; What Should Investors Do?

The funds will be used to purchase outstanding optionally convertible debentures issued by the company’s subsidiary Biocon ...

The decision comes after receiving approvals from the Board of Directors in April and from shareholders through a postal ...

Shares of Biocon Ltd., surged 1.3% on Tuesday after the company's board of directors approved the floor price for the share ...

The company has set the floor price for the issue at Rs 340.20 per equity share, in line with the pricing formula prescribed ...

Biocon shares will be in focus of stock market investors on Tuesday, 17 June 2025, after the company's board of directors ...

Bengaluru-based Biocon Ltd. closes the window to list its arm, Biocon Biologics Ltd., as it raises Rs 4,500 crore to provide ...

Biocon launches Rs 4,500-crore QIP to raise funds for debt repayment, Biocon Biologics investment, and corporate needs ...

Biocon has launched a ₹4,500 crore Qualified Institutional Placement, setting the floor price at ₹340.20 per share. Proceeds ...

Biocon Ltd, a global bio-pharmaceutical firm, plans to launch a qualified institutional placement (QIP) soon to raise up to ...

Indian drug companies are preparing to launch low-cost versions of Novo Nordisk’s Wegovy and Ozempic as patents expire in 2026, making weight-loss and diabetes treatment more affordable worldwide.

Biotechnology giant, Biocon Ltd, announced setting a floor price of ₹340.2 per equity share for its qualified institutions ...